HT Pharma is a strategic consulting and investment firm dedicated to US-China Pharma/Life Science partnership opportunities. Its principals include US-China Pharma/Life science industry veterans and ex Chinese government officials. Leveraging its deep knowledge base and strong relationship within US and China Pharma/Life Sciences industry and government, HT Pharma helps US firms to gain market entry in China, and to channel US investments to Chinese Pharma/Life Science industry. It also advises Chinese clients on US market entry, strategic partnership, financing and regulatory issues.

HT Pharma is an organizer of US-China Pharma/Life Science Conference on June 14th, at Harvard Club of New York City

HT Pharma is the New York Region Partner for the China Access forum in New York City on April 7th, 2005

HT Pharma partner with SRI on Conference: Impact China: Pharmaceutical R&D Global Summit 2005,
September 18 to 21, 2005 • Renaissance Shanghai Pudong Hotel - Shanghai, China
(www.srinstitute.com/china)